Gleneagles India: Advancing Clinical Excellence & Patient Care

Gleneagles Healthcare India, a renowned healthcare provider in India, has recently announced a significant rebranding initiative across its six hospitals in Mumbai, Chennai, Bengaluru, and Hyderabad. The hospitals have been unified under the new identity of 'Gleneagles Hospitals,' a signature international brand of IHH Healthcare. 

The rebranding initiative and renovated visitor touchpoints, such as hospital entrances and reception areas, reflect Gleneagles Healthcare India's commitment to providing patient-centric care by leveraging IHH's global expertise and best practices. 

Since IHH Healthcare, a leading integrated healthcare provider, acquired a majority stake in Gleneagles Healthcare India in 2015, the hospital chain has witnessed further investment and growth. Last year, IHH increased its stake to almost 100% in August, making Gleneagles Healthcare India a distinguished chain of multi-super specialty hospitals.

The hospital chain is renowned for delivering the highest standard of tertiary and quaternary healthcare services, including specializing in comprehensive multi-organ transplant services. It is a dominant player in the healthcare sector, boasting over 1,500 beds across its state-of-the-art facilities that highly skilled healthcare professionals staff. 

Dr Prem Kumar Nair, group CEO of IHH Healthcare, said, "We are thrilled to debut Gleneagles Hospitals in India after our strategic investment last August. This new identity embodies our commitment to clinical excellence and innovation. 

The new name is apt and timely as we seek to expand organically within India, backed by the strong legacy of the Gleneagles brand, which originates in our 65-year-old Gleneagles Hospital in Singapore. 

I am confident that Gleneagles Healthcare India will build on the brand's commitment to provide world-class excellence, from superior clinical outcomes to the highest standards of quality and care."